SAN JOSE, Calif. – Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California. The lawsuit, filed September 30, alleges that Illumina and its customers are using various gene sequencers and related reagents, including NovaSeq 6000, HiSeq X Ten, HiSeq 3000, and HiSeq 4000, […]
HSINCHU, Taiwan – Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a complaint in the U.S. District Court for the District of Delawareagainst Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the […]
Company has been issued 10 patents in 2019 for its single-cell technology and key applications Ann Arbor, Mich. — Celsee, Inc., today announced the issuance of U.S. Patent No. 10,416,070, entitled “Cell capture system and method of use,†which covers the automation of single-cell partitioning. Celsee has been issued ten patents by the U.S. Patent […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. in the United States District Court for the District of Delaware. In the lawsuit Bio-Rad asserts that 10X Genomics infringes U.S. Patent […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has filed new legal action in the United States District Court for the Northern District of California seeking to stop the infringement of its patented technology by IONpath. In the complaint, Fluidigm alleges that […]
Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene… DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for Merck’s CRISPR genome-editing technology Merck has 20 allowed CRISPR patents to […]
Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and therapeutics company, […]
EChrom and Pannatek Admit to using Agilent Technology Without Permission, Agree to Pay Damages and Cease Using Agilent Technology SANTA CLARA, Calif.–Agilent Technologies, Inc. (NYSE: A) today announced that the company has reached agreement with China-based companies EChrom and Pannatek, as well as certain former Agilent employees, regarding an intellectual property dispute related to Agilent […]
DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product […]
Newomics announces today the issuance of US patent 10,338,079, entitled, “Methods and Systems for Diagnosing Diseases.” The patent is part of the company’s expanding intellectual property portfolio for microfluidics and diagnostics.
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
